Mauritania + 1 more

First delivery of German-donated COVID vaccines to COVAX land in Mauritania, with other deliveries to follow

Format
News and Press Release
Source
Posted
Originally published
Origin
View original
  • As part of its commitment to supply 100 million doses of COVID-19 vaccines, mainly to developing countries and primarily via COVAX, the first doses donated by Germany are landing in Mauritania on 8 September 2021. The next shipments are set to arrive in Tajikistan on 9 September, Uzbekistan on 10 September, Sudan on 11 September and Ethiopia on 13 September. These will later be followed by Botswana and Namibia, among other countries.

  • Chancellor Angela Merkel: “COVAX is the most important multilateral initiative for ensuring equitable access to and distribution of COVID-19 vaccines. I am therefore delighted that today COVAX can start supplying the first 1.3 million German vaccine doses to the countries that currently need them most, with many more to follow in the weeks ahead.”

  • Dr Seth Berkley, CEO, Gavi, the Vaccine Alliance: “Germany has been a major supporter of COVAX and a true leader in global health, having pledged both significant funding and vaccine doses. We are thankful to Germany for sharing the responsibility of ending the acute stage of the pandemic through the conversion of these pledges into deliveries.”

Geneva, 8 September 2021 – Building on its pledge of EUR 1.62 billion to COVAX, the German government has donated the first batch of its pledge of 100 million doses of COVID-19 vaccines, the majority of which will be delivered via COVAX. The first deliveries of AstraZeneca vaccines from this donation land today in Mauritania (213,600 doses), with the next tranches set to arrive in Tajikistan (100,800 doses) on 9 September, Uzbekistan (356,000 doses) on 10 September, Sudan (357,600 doses) on 11 September and Ethiopia (271,200 doses) on 13 September. These will be later followed by a second allocation of doses that will include Botswana (101,760 doses) and Namibia (117,120 doses), among other countries.

Germany’s significant dose-sharing commitment comes alongside strong financial support to COVAX and significant additional funding pledged to the Access to COVID-19 Tools (ACT) Accelerator. With the total funding of nearly EUR 2.2 billion, Germany is the second largest donor to the ACT-Accelerator. Alongside support for the Gavi COVAX AMC, German funding contributes to the reinforcement of diagnostics, therapeutics and health systems to combat COVID-19 around the world – because no-one is safe until everyone is safe. This dose donation by Germany allows COVAX to deliver more vaccines in the third quarter of this year, before supply from COVAX purchase agreements increases in Q4, meaning that more people will be able to access vaccines now, at a time when variants are a major threat to global health and stability.

“Germany has been a major supporter of COVAX and a true leader in global health, having pledged both significant funding and vaccine doses. We are thankful to Germany for sharing the responsibility of ending the acute stage of the pandemic through the conversion of these pledges into deliveries,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, which leads on procurement and delivery at scale for COVAX. “This dose donation enables COVAX to reach some of those most in need of protection, and we are grateful to the German government and the German people for their continued support.”

Chancellor Angela Merkel stressed: “COVAX is the most important multilateral initiative for ensuring equitable access to and distribution of COVID-19 vaccines. I am therefore delighted that today COVAX can start supplying the first 1.3 million German vaccine doses to the countries that currently need them most, with many more to follow in the weeks ahead.”

These doses donated by Germany are produced by the AstraZeneca manufacturing network. Donating through COVAX helps to increase vaccine coverage, ensures that no dose goes to waste, and helps to bring an end to the acute phase of the pandemic. The design and operationalization of the COVAX dose sharing mechanism is being supported by a contribution of CAD 5 million from Canada.

The donation of doses via COVAX are enabled via tripartite agreements between Gavi, manufacturers, and donating countries. The shipments to countries will be enabled by COVAX delivery partners UNICEF and the Pan American Health Organisation (PAHO).

Over 600 million doses have already been pledged to COVAX by a number of countries in response to short-term supply challenges and the rise of new variants. Working with donor governments to operationalise growing numbers of dose-sharing pledges, COVAX expects to see more deliveries of donated doses in the weeks and months to come.